Dasatinib Drugs Market Report 2026
Download Free Sample Buy Now
Dasatinib Drugs Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Dasatinib Drugs Market Report 2026

Global Outlook – By Product Type (Tablets, Oral Suspension, Other Products), By Indication (Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Other Indications), By End User (Hospitals, Specialty Clinics, Home Healthcare) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Dasatinib Drugs Market Overview

• Dasatinib Drugs market size has reached to $1.53 billion in 2025

• Expected to grow to $2.08 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%

• Growth Driver: Rising Prevalence Of Chronic Myeloid Leukemia (CML) Fuels Growth Of Dasatinib Drugs Market

• Market Trend: Generic Dasatinib Boosting Competition And Accessibility

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Dasatinib Drugs Market?

Dasatinib drugs refer to a type of targeted therapy known as tyrosine kinase inhibitors, primarily used to treat blood cancers, such as chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). They work by blocking proteins that drive cancer cell growth, helping to slow disease progression. This leads to improved survival rates and better management of the disease.

The main types of products in the dasatinib drugs market are tablets, oral suspension, and others. Dasatinib is primarily available in tablet form, which makes it convenient for patients to take orally. The various indications include chronic myeloid leukemia, acute lymphoblastic leukemia, and others, and several end users including hospitals, specialty clinics, and home healthcare.

Dasatinib Drugs Market Global Report 2026 Market Report bar graph

What Is The Dasatinib Drugs Market Size and Share 2026?

The dasatinib drugs market size has grown strongly in recent years. It will grow from $1.53 billion in 2025 to $1.63 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to approval of tyrosine kinase inhibitors for leukemia, increasing prevalence of chronic myeloid leukemia, clinical success of dasatinib in resistant cases, expansion of oncology treatment centers, availability of oral targeted therapies.

What Is The Dasatinib Drugs Market Growth Forecast?

The dasatinib drugs market size is expected to see strong growth in the next few years. It will grow to $2.08 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to growth in leukemia patient population, rising demand for personalized cancer treatment, increased penetration of generic oncology drugs, expansion of home-based cancer care, advancements in targeted drug development. Major trends in the forecast period include rising adoption of targeted cancer therapies, increasing use of oral oncology drugs, growing demand for generic dasatinib products, expansion of combination therapy approaches, improved patient adherence through oral formulations.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Dasatinib Drugs Market Segmentation

1) By Product Type: Tablets, Oral Suspension, Other Products

2) By Indication: Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Other Indications

3) By End User: Hospitals, Specialty Clinics, Home Healthcare

Subsegments:

1) By Tablets: 20 mg Tablets, 50 mg Tablets, 70 mg Tablets, 80 mg Tablets

2) By Oral Suspension: 20 mg Or 5 mL Oral Suspension, 40 mg Or 5 mL Oral Suspension

3) By Other Products: Combination Therapies, Generic Dasatinib Products

What Is The Driver Of The Dasatinib Drugs Market?

The increasing prevalence of chronic myeloid leukemia (CML) is expected to propel the growth of the dasatinib drug market going forward. Chronic myeloid leukemia (CML) is a cancer of the bone marrow and blood characterized by uncontrolled growth of abnormal white blood cells. The rising prevalence of CML is driven by increasing environmental exposures and lifestyle-related risk factors. The dasatinib drug market supports disease management by inhibiting the BCR-ABL tyrosine kinase protein responsible for the uncontrolled proliferation of leukemic cells. For instance, in January 2023, according to the American Cancer Society (ACS), a US-based cancer-focused health organization, CML cases in the United States increased to 8,930 in 2023, up from 8,860 cases in 2022. Therefore, the increasing prevalence of chronic myeloid leukemia (CML) is driving the growth of the dasatinib drug industry.

Key Players In The Global Dasatinib Drugs Market

Major companies operating in the dasatinib drugs market are Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Sun Pharmaceutical Industries Limited, Hetero Drugs Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Intas Pharmaceuticals Ltd., Cipla Limited, Lupin Limited, MSN Laboratories Pvt. Ltd., Hikma Pharmaceuticals plc, Zhejiang Hisun Pharmaceutical Co. Ltd., Biocon Limited, Alkem Laboratories Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Mylan N.V., Manus Aktteva Biopharma LLP

Global Dasatinib Drugs Market Trends and Insights

Major companies operating in the dasatinib drugs market are focusing on developing generic drugs to expand market reach, offer cost-effective treatment alternatives, and improve accessibility for patients requiring long-term cancer therapy. Generic dasatinib medicines refer to therapeutically equivalent formulations of the branded drug that deliver the same active ingredient, strength, quality, and clinical efficacy at a lower cost, thereby increasing affordability, promoting competition, and reducing the financial burden on patients and healthcare systems. For instance, in September 2024, Apotex Corp., a Canada-based pharmaceutical company, launched the first generic version of Sprycel (dasatinib) in the United States for treating certain types of leukemia in adults and children, offering a high-quality, lower-cost alternative that enhances treatment access and supports competitive pricing within the dasatinib drugs market.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Dasatinib Drugs Market?

In January 2025, Handa Therapeutics, a US-based healthcare technology company, acquired PHYRAGO (dasatinib) tablets, an FDA-approved treatment for chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, from Nanocopoeia, LLC, for an undisclosed amount. With this acquisition, Handa Therapeutics aims to strengthen its oncology portfolio and expand its presence in the chronic myeloid leukemia (CML) therapeutics market. Nanocopoeia, LLC, is a US-based biopharmaceutical company that specializes in developing and manufacturing a specific formulation of the dasatinib drug.

Regional Insights

North America was the largest region in the dasatinib drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Dasatinib Drugs Market?

The dasatinib drugs market consists of sales of sprycel and generic dasatinib. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Dasatinib Drugs Market Report 2026?

The dasatinib drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dasatinib drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Dasatinib Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.63 billion
Revenue Forecast In 2035 $2.08 billion
Growth Rate CAGR of 6.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product Type, Indication, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Sun Pharmaceutical Industries Limited, Hetero Drugs Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Intas Pharmaceuticals Ltd., Cipla Limited, Lupin
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Dasatinib Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Dasatinib Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Dasatinib Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Dasatinib Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Adoption Of Targeted Cancer Therapies

4.2.2 Increasing Use Of Oral Oncology Drugs

4.2.3 Growing Demand For Generic Dasatinib Products

4.2.4 Expansion Of Combination Therapy Approaches

4.2.5 Improved Patient Adherence Through Oral Formulations

5. Dasatinib Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Oncology Clinics

5.3 Cancer Treatment Centers

5.4 Home Healthcare Providers

5.5 Research And Academic Institutions

6. Dasatinib Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Dasatinib Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Dasatinib Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Dasatinib Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Dasatinib Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Dasatinib Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Dasatinib Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Dasatinib Drugs Market Segmentation

9.1. Global Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tablets, Oral Suspension, Other Products

9.2. Global Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Other Indications

9.3. Global Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Home Healthcare

9.4. Global Dasatinib Drugs Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20 mg Tablets, 50 mg Tablets, 70 mg Tablets, 80 mg Tablets

9.5. Global Dasatinib Drugs Market, Sub-Segmentation Of Oral Suspension, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20 mg Or 5 mL Oral Suspension, 40 mg Or 5 mL Oral Suspension

9.6. Global Dasatinib Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Combination Therapies, Generic Dasatinib Products

10. Dasatinib Drugs Market Regional And Country Analysis

10.1. Global Dasatinib Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Dasatinib Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Dasatinib Drugs Market

11.1. Asia-Pacific Dasatinib Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Dasatinib Drugs Market

12.1. China Dasatinib Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Dasatinib Drugs Market

13.1. India Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Dasatinib Drugs Market

14.1. Japan Dasatinib Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Dasatinib Drugs Market

15.1. Australia Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Dasatinib Drugs Market

16.1. Indonesia Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Dasatinib Drugs Market

17.1. South Korea Dasatinib Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Dasatinib Drugs Market

18.1. Taiwan Dasatinib Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Dasatinib Drugs Market

19.1. South East Asia Dasatinib Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Dasatinib Drugs Market

20.1. Western Europe Dasatinib Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Dasatinib Drugs Market

21.1. UK Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Dasatinib Drugs Market

22.1. Germany Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Dasatinib Drugs Market

23.1. France Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Dasatinib Drugs Market

24.1. Italy Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Dasatinib Drugs Market

25.1. Spain Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Dasatinib Drugs Market

26.1. Eastern Europe Dasatinib Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Dasatinib Drugs Market

27.1. Russia Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Dasatinib Drugs Market

28.1. North America Dasatinib Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Dasatinib Drugs Market

29.1. USA Dasatinib Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Dasatinib Drugs Market

30.1. Canada Dasatinib Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Dasatinib Drugs Market

31.1. South America Dasatinib Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Dasatinib Drugs Market

32.1. Brazil Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Dasatinib Drugs Market

33.1. Middle East Dasatinib Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Dasatinib Drugs Market

34.1. Africa Dasatinib Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Dasatinib Drugs Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Dasatinib Drugs Market Regulatory and Investment Landscape

36. Dasatinib Drugs Market Competitive Landscape And Company Profiles

36.1. Dasatinib Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Dasatinib Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Dasatinib Drugs Market Company Profiles

36.3.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sandoz Group AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Hetero Drugs Limited Overview, Products and Services, Strategy and Financial Analysis

37. Dasatinib Drugs Market Other Major And Innovative Companies

Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Intas Pharmaceuticals Ltd., Cipla Limited, Lupin Limited, MSN Laboratories Pvt. Ltd., Hikma Pharmaceuticals plc, Zhejiang Hisun Pharmaceutical Co. Ltd., Biocon Limited, Alkem Laboratories Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Mylan N.V., Manus Aktteva Biopharma LLP

38. Global Dasatinib Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Dasatinib Drugs Market

40. Dasatinib Drugs Market High Potential Countries, Segments and Strategies

40.1 Dasatinib Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Dasatinib Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Dasatinib Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Dasatinib Drugs Market, Overview Of Key Products - Product Examples
  • Table 2: Global Dasatinib Drugs Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Dasatinib Drugs Market, Supply Chain Analysis
  • Table 4: Global Dasatinib Drugs Market, Major Raw Material Providers
  • Table 5: Global Dasatinib Drugs Market, Major Resource Providers
  • Table 6: Global Dasatinib Drugs Market, Major Manufacturers (Suppliers)
  • Table 7: Global Dasatinib Drugs Market, Major Distributors And Channel Partners
  • Table 8: Global Dasatinib Drugs Market, Key Technologies & Future Trends
  • Table 9: Global Dasatinib Drugs Market, Major Trends
  • Table 10: Global Dasatinib Drugs Market, Major End Users
  • Table 11: Global Dasatinib Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Dasatinib Drugs Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Dasatinib Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Dasatinib Drugs Market - TAM, US$ Billion, 2025
  • Table 15: Global Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Dasatinib Drugs Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Dasatinib Drugs Market, Sub-Segmentation Of Oral Suspension, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Dasatinib Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Dasatinib Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Dasatinib Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Dasatinib Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Dasatinib Drugs Market - Company Scoring Matrix
  • Table 97: Bristol-Myers Squibb Company Financial Performance
  • Table 98: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 99: Sandoz Group AG Financial Performance
  • Table 100: Sun Pharmaceutical Industries Limited Financial Performance
  • Table 101: Hetero Drugs Limited Financial Performance
  • Table 102: Global Dasatinib Drugs Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Dasatinib Drugs Market, Competitive Dashboard
  • Table 104: Global Dasatinib Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Dasatinib Drugs Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Table 106: Global, Dasatinib Drugs Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 107: Global, Dasatinib Drugs Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Dasatinib Drugs Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Dasatinib Drugs Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Dasatinib Drugs Market, Supply Chain Analysis
  • Figure 4: Global Dasatinib Drugs Market, Major Raw Material Providers
  • Figure 5: Global Dasatinib Drugs Market, Major Resource Providers
  • Figure 6: Global Dasatinib Drugs Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Dasatinib Drugs Market, Major Distributors And Channel Partners
  • Figure 8: Global Dasatinib Drugs Market, Key Technologies & Future Trends
  • Figure 9: Global Dasatinib Drugs Market, Major Trends
  • Figure 10: Global Dasatinib Drugs Market, Major End Users
  • Figure 11: Global Dasatinib Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Dasatinib Drugs Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Dasatinib Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Dasatinib Drugs Market - TAM, US$ Billion, 2025
  • Figure 15: Global Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Dasatinib Drugs Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Dasatinib Drugs Market, Sub-Segmentation Of Oral Suspension, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Dasatinib Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Dasatinib Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Dasatinib Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Dasatinib Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Dasatinib Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Dasatinib Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Dasatinib Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Dasatinib Drugs Market - Company Scoring Matrix
  • Figure 97: Bristol-Myers Squibb Company Financial Performance
  • Figure 98: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 99: Sandoz Group AG Financial Performance
  • Figure 100: Sun Pharmaceutical Industries Limited Financial Performance
  • Figure 101: Hetero Drugs Limited Financial Performance
  • Figure 102: Global Dasatinib Drugs Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Dasatinib Drugs Market, Competitive Dashboard
  • Figure 104: Global Dasatinib Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Dasatinib Drugs Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Figure 106: Global, Dasatinib Drugs Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 107: Global, Dasatinib Drugs Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Read More About Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Read More About Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Read More About Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Fats And Oils Market 2023 – By Type (Fats, Oils), By Product Type (Palm Oil, Sunflower Oil, Olive Oil, Soybean Oil, Rapeseed Oil, Other Product Types), By Source (Plants, Animals), By Distribution Channel (Supermarkets/H...

Gastrointestinal Endoscopy Market 2024 – By Product (Endoscopes, Camera Heads, Visualization Systems, Biopsy Devices, Capsule Endoscopes, Transmitters And Receivers, Robot-Assisted Endoscopes, Other Products.), By Proced...

Lung Cancer Drugs Market Report 2026 - Global Outlook – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs ), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung canc...

Blood Cancer Drugs Market Report 2026 - Global Outlook – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan Or Mabthera (Rituximab), Gleevec Or Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), ...

Sequencing Consumables Market Report 2026 - Global Outlook – By Product (Kits, Reagents, Accessories), By Platform (1st Generation Sequencing Consumables, 2nd Generation Sequencing Consumables, 3rd Generation Sequencing ...

Skin Cancer Drugs Market Report 2026 - Global Outlook – By Type (Actinic Keratoses (AK), Basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), Melanoma ), By Drug Class (Chemotherapy, Immunotherapy, Targeted Agents ...

Breast Cancer Drugs Market Report 2026 - Global Outlook – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Othe...

Aerospace Helmet Mounted Display Market Report 2026 - Global Outlook – By Component ( Processor And Memory, Controller, Sensor, Display, Lens, Other Components ), By Technology ( Augmented Reality, Virtual Reality ), By ...

Frequently Asked Questions

The Dasatinib Drugs market was valued at $1.53 billion in 2025, increased to $1.63 billion in 2026, and is projected to reach $2.08 billion by 2030.

The global Dasatinib Drugs market is expected to grow at a CAGR of 6.3% from 2026 to 2035 to reach $2.08 billion by 2035.

Some Key Players in the Dasatinib Drugs market Include, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Sun Pharmaceutical Industries Limited, Hetero Drugs Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories

Major trend in this market includes: Generic Dasatinib Boosting Competition And Accessibility. For further insights on this market. request a sample here

North America was the largest region in the dasatinib drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dasatinib drugs market report are Asia-Pacific, South Ea

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us